
The Chinese OTC drugs market presents a lucrative billion-dollar opportunity for Indian pharmaceutical companies. In 2019, China’s National Medical Products Administration launched a trial program to introduce over-the-counter (OTC) products through bonded warehouses in CBEC (Cross-Border eCommerce) Free Trade Zones. This initiative, now expanded to multiple regions, enables the sale...









